Clinical, tactical and strategic benefits of a UK Spray Dried Plasma production capability

Matt Ellington, E Barnard, L Bower, S Huish, L Green, P Moor, T Woolley, R Cardigan

Open source

DOI
10.1136/military-2024-002875
Published
2025-04-03
Container
BMJ Military Health
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/military-2024-002875,
  title = {Clinical, tactical and strategic benefits of a UK Spray Dried Plasma production capability},
  author = {Matt Ellington and E Barnard and L Bower and S Huish and L Green and P Moor and T Woolley and R Cardigan},
  year = {2025},
  journal = {BMJ Military Health},
  doi = {10.1136/military-2024-002875},
  url = {https://doi.org/10.1136/military-2024-002875}
}

RIS

TY  - JOUR
TI  - Clinical, tactical and strategic benefits of a UK Spray Dried Plasma production capability
AU  - Matt Ellington
AU  - E Barnard
AU  - L Bower
AU  - S Huish
AU  - L Green
AU  - P Moor
AU  - T Woolley
AU  - R Cardigan
PY  - 2025
JO  - BMJ Military Health
DO  - 10.1136/military-2024-002875
UR  - https://doi.org/10.1136/military-2024-002875
ER  - 

APA

Ellington, M., Barnard, E., Bower, L., Huish, S., Green, L., Moor, P., Woolley, T., & Cardigan, R. (2025). Clinical, tactical and strategic benefits of a UK Spray Dried Plasma production capability. BMJ Military Health. https://doi.org/10.1136/military-2024-002875

Source records